Symptom validity indices for the Beck Depression Inventory-II: development and cross-validation in research and clinical samples

被引:1
|
作者
Shura, Robert D. [1 ,2 ,3 ]
Schroeder, Ryan W. [4 ]
Ord, Anna S. [5 ]
Bieu, Rachel K. [4 ]
O'Connor, Victoria L. [1 ,2 ,3 ]
Magnante, Anna T. [1 ,2 ,3 ,8 ]
Snodgrass, Makenna [4 ,6 ]
Miskey, Holly M. [1 ,2 ,3 ]
Martindale, Sarah L. [1 ,2 ,7 ]
Rowland, Jared A. [1 ,2 ,7 ]
机构
[1] WG Bill Hefner VA Healthcare Syst, Salisbury, NC USA
[2] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA
[3] Wake Forest Sch Med, Dept Neurol, Winston Salem, NC USA
[4] Robert J Dole VA Med Ctr, Wichita, KS USA
[5] Regent Univ, Sch Psychol & Counseling, Virginia Beach, VA USA
[6] Wichita State Univ, Wichita, KS USA
[7] Wake Forest Sch Med, Dept Translat Neurosci, Winston Salem, NC USA
[8] Cascade Neuropsychol & Regent Univ, Virginia Beach, VA USA
关键词
BDI-II; SVT; symptom validity; veteran; depression; PERSONALITY-ASSESSMENT INVENTORY;
D O I
10.1080/13854046.2024.2432058
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: The present study sought to cross validate the recently developed total score cut-off for the Beck Depression Inventory-II (BDI-II) and identify additional embedded symptom validity indices within this commonly used self-report depression measure. Methods: Study 1 included a research sample of 379 veterans with diagnostic subgroups of Current and Lifetime Depression and Current and Lifetime Posttraumatic Stress Disorder (PTSD). Study 2 included a clinical sample of 224 veterans with diagnostic subgroups of Current Depression, Lifetime Depression, and No Depression. Three embedded BDI-II symptom validity indices were examined in the total samples and subgroups: the BDI-II Symptom Severity Scale (total raw score), BDI-II Extreme Symptom Scale (summed frequency of extreme responses), and the BDI-II Rare Items Scale (summed frequency of rarely endorsed items). Validity indices from the Personality Assessment Inventory were utilized in both studies, with the Miller Forensic Assessment of Symptoms Test also used in Study 1. Results: In Study 1, BDI-II validity index cut-off scores had to be adjusted the highest for the Current Depression or Current PTSD subgroups. The cut-offs were associated with sensitivity rates ranging from 0.12 to 0.53 and specificity rates ranging from 0.90 to 0.96. In Study 2, cut-offs had to be adjusted, the highest for the Current Depression subgroup. Identified cut-offs had sensitivity rates ranging from 0.22 to 0.65 and specificity rates ranging from 0.89 to 0.95. Conclusions: This study supports the use of all three proposed BDI-II embedded symptom validity indices.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Criterion validity, severity cut scores, and test-retest reliability of the Beck Depression Inventory-II in a university counseling center sample
    Sprinkle, SD
    Lurie, D
    Insko, SL
    Atkinson, G
    Jones, GL
    Logan, AR
    Bissada, NN
    JOURNAL OF COUNSELING PSYCHOLOGY, 2002, 49 (03) : 381 - 385
  • [42] Psychometric Properties of the Bangla Version of the Beck Depression Inventory-II (BDI-II) With University Students in Bangladesh: A Cross-Sectional Study
    Hasan, Md. Torun
    Khan, Mozibul H. A.
    HEALTH SCIENCE REPORTS, 2025, 8 (01)
  • [43] Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease
    Phan, Tina
    Carter, Owen
    Adams, Claire
    Waterer, Grant
    Chung, Li Ping
    Hawkins, Maxine
    Rudd, Cobie
    Ziman, Mel
    Strobel, Natalie
    CHRONIC RESPIRATORY DISEASE, 2016, 13 (03) : 220 - 228
  • [44] Turkish Validity & Reliability of The Quick Inventory of Depressive Symptomatology Adolescent Version (QIDS-A17-SR) In Comparison with The Beck Depression Inventory-II Among Late Adolescents
    Mergen, Berna Erdogmus
    Arslan, Hakan
    Arslan, Ebru
    Mergen, Haluk
    Turguts, Sibel Erturk
    Bernstein, Ira H.
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2016, 26 (03): : 303 - 309
  • [45] AN ANXIETY SCALE FOR THE STRONG VOCATIONAL-INTEREST INVENTORY - DEVELOPMENT, CROSS-VALIDATION, AND SUBSEQUENT TESTS OF VALIDITY
    GARMAN, GD
    UHR, L
    JOURNAL OF APPLIED PSYCHOLOGY, 1958, 42 (04) : 241 - 246
  • [46] Giving G a Meaning: An Application of the Bifactor-(S-1) Approach to Realize a More Symptom-Oriented Modeling of the Beck Depression Inventory-II
    Heinrich, Manuel
    Zagorscak, Pavle
    Eid, Michael
    Knaevelsrud, Christine
    ASSESSMENT, 2020, 27 (07) : 1429 - 1447
  • [47] A Multi-Informant Approach to Measuring Depressive Symptoms in Clinical Assessments of Adolescent Social Anxiety Using the Beck Depression Inventory-II: Convergent, Incremental, and Criterion-Related Validity
    Erica Rausch
    Sarah J. Racz
    Tara M. Augenstein
    Lauren Keeley
    Melanie F. Lipton
    Sebastian Szollos
    James Riffle
    Daniel Moriarity
    Rachelle Kromash
    Andres De Los Reyes
    Child & Youth Care Forum, 2017, 46 : 661 - 683
  • [48] A Multi-Informant Approach to Measuring Depressive Symptoms in Clinical Assessments of Adolescent Social Anxiety Using the Beck Depression Inventory-II: Convergent, Incremental, and Criterion-Related Validity
    Rausch, Erica
    Racz, Sarah J.
    Augenstein, Tara M.
    Keeley, Lauren
    Lipton, Melanie F.
    Szollos, Sebastian
    Riffle, James
    Moriarity, Daniel
    Kromash, Rachelle
    De Los Reyes, Andres
    CHILD & YOUTH CARE FORUM, 2017, 46 (05) : 661 - 683
  • [49] The Beck Depression Inventory-II as a screening tool of depression in the Chinese adolescent population in Hong Kong: A validation study using the Composite International Diagnostic Interview as the gold standard
    Yang, Xue
    Stewart, Sunita Mahtani
    ASIAN JOURNAL OF PSYCHIATRY, 2020, 52
  • [50] Factor Analysis of the Beck Depression Inventory-II and Long-Term Hematopoietic Stem Cell Transplantation Survival Using the Research Domain Criteria Framework
    Kirsch, Janae L.
    Ehlers, Shawna L.
    TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (03): : 205.e1 - 205.e7